{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:29:56Z","timestamp":1722889796467},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T00:00:00Z","timestamp":1489190400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s10689-017-9977-x","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T08:40:06Z","timestamp":1489221606000},"page":"461-469","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer"],"prefix":"10.1007","volume":"16","author":[{"name":"for the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bressel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Picken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Camm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Kiely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Hopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"issue":"2","key":"9977_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/jmedgenet-2013-101974","volume":"51","author":"RM Brohet","year":"2014","unstructured":"Brohet RM, Velthuizen ME, Hogervorst FB et al (2014) Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. J Med Genet 51(2):98\u2013107. doi: 10.1136\/jmedgenet-2013-101974","journal-title":"J Med Genet"},{"issue":"12","key":"9977_CR2","first-page":"3776","volume":"8","author":"JM Satagopan","year":"2002","unstructured":"Satagopan JM, Boyd J, Kauff ND et al (2002) Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Clin Cancer Res 8(12):3776\u20133781","journal-title":"Clin Cancer Res"},{"issue":"5","key":"9977_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"5645","key":"9977_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. doi: 10.1126\/science.1088759","journal-title":"Science"},{"issue":"3","key":"9977_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"32","key":"9977_CR6","doi-asserted-by":"publisher","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","volume":"26","author":"K Levanon","year":"2008","unstructured":"Levanon K, Crum C, Drapkin R (2008) New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26(32):5284\u20135293. doi: 10.1200\/JCO.2008.18.1107","journal-title":"J Clin Oncol"},{"issue":"7","key":"9977_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jmedgenet-2015-103077","volume":"52","author":"S Jervis","year":"2015","unstructured":"Jervis S, Song H, Lee A et al (2015) A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. J Med Genet 52(7):465\u2013475. doi: 10.1136\/jmedgenet-2015-103077","journal-title":"J Med Genet"},{"issue":"10022","key":"9977_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A et al (2016) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387(10022):945\u2013956. doi: 10.1016\/S0140-6736(15)01224-6","journal-title":"Lancet"},{"issue":"2","key":"9977_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","volume":"14","author":"MB Daly","year":"2016","unstructured":"Daly MB, Pilarski R, Axilbund JE et al (2016) Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015. J Natl Compr Canc Netw 14(2):153\u2013162","journal-title":"J Natl Compr Canc Netw"},{"key":"9977_CR10","unstructured":"Cancer Australia (2011) Recommendations for management of women at high risk of ovarian cancer. Cancer Australia, Surry hills, NSW. Accessed 01 May 2016"},{"issue":"8","key":"9977_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337. doi: 10.1200\/JCO.2007.13.9626","journal-title":"J Clin Oncol"},{"issue":"2","key":"9977_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387. doi: 10.1093\/jnci\/djn442","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"9977_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","volume":"32","author":"AP Finch","year":"2014","unstructured":"Finch AP, Lubinski J, Moller P et al (2014) Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol 32(15):1547\u20131553. doi: 10.1200\/JCO.2013.53.2820","journal-title":"J Clin Oncol"},{"issue":"9","key":"9977_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975. doi: 10.1001\/jama.2010.1237","journal-title":"JAMA"},{"issue":"25","key":"9977_CR15","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F et al (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985\u20133990. doi: 10.1200\/JCO.2007.12.2622","journal-title":"J Clin Oncol"},{"issue":"29","key":"9977_CR16","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1200\/JCO.2013.54.1987","volume":"32","author":"ME Sherman","year":"2014","unstructured":"Sherman ME, Piedmonte M, Mai PL et al (2014) Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199. J Clin Oncol 32(29):3275\u20133283. doi: 10.1200\/JCO.2013.54.1987","journal-title":"J Clin Oncol"},{"issue":"15","key":"9977_CR17","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1200\/JCO.2013.54.8925","volume":"32","author":"PL Mai","year":"2014","unstructured":"Mai PL, Loud JT, Greene MH (2014) A major step forward for BRCA1\/2-related cancer risk management. J Clin Oncol 32(15):1531\u20131533. doi: 10.1200\/JCO.2013.54.8925","journal-title":"J Clin Oncol"},{"issue":"9","key":"9977_CR18","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1097\/IGC.0b013e3182a80ac8","volume":"23","author":"SL Wethington","year":"2013","unstructured":"Wethington SL, Park KJ, Soslow RA et al (2013) Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer 23(9):1603\u20131611. doi: 10.1097\/IGC.0b013e3182a80ac8","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"9977_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","volume":"22","author":"PA Shaw","year":"2009","unstructured":"Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H (2009) Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers. Mod Pathol 22(9):1133\u20131138. doi: 10.1038\/modpathol.2009.89","journal-title":"Mod Pathol"},{"issue":"6","key":"9977_CR20","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","volume":"194","author":"JD Lamb","year":"2006","unstructured":"Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM (2006) Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol 194(6):1702\u20131709. doi: 10.1016\/j.ajog.2006.03.006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"9977_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10689-011-9435-0","volume":"10","author":"BE Kiely","year":"2011","unstructured":"Kiely BE, Friedlander ML, Milne RL et al (2011) Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Fam Cancer 10(3):505\u2013514. doi: 10.1007\/s10689-011-9435-0","journal-title":"Fam Cancer"},{"key":"9977_CR22","unstructured":"Kathleen Cunningham Consortium for Research into Familial Breast Cancer (kConFab). http:\/\/www.kconfab.org\/Collection\/Eligibility.shtml . Accessed 1 May 2016"},{"issue":"2","key":"9977_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10689-004-6129-x","volume":"4","author":"KA Phillips","year":"2005","unstructured":"Phillips KA, Butow PN, Stewart AE et al (2005) Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 4(2):105\u2013113. doi: 10.1007\/s10689-004-6129-x","journal-title":"Fam Cancer"},{"key":"9977_CR24","unstructured":"Australian Health Practitioner Regulation Agency (APHRA). https:\/\/www.ahpra.gov.au\/ . Accessed 1 Dec 2015"},{"issue":"12","key":"9977_CR25","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","volume":"35","author":"K Visvanathan","year":"2011","unstructured":"Visvanathan K, Vang R, Shaw P et al (2011) Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study. Am J Surg Pathol 35(12):1766\u20131775. doi: 10.1097\/PAS.0b013e31822f58bc","journal-title":"Am J Surg Pathol"},{"key":"9977_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.1820","author":"CA Shu","year":"2016","unstructured":"Shu CA, Pike MC, Jotwani AR et al (2016) Uterine cancer after risk-reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations. JAMA Oncol doi: 10.1001\/jamaoncol.2016.1820","journal-title":"JAMA Oncol"},{"key":"9977_CR27","doi-asserted-by":"crossref","unstructured":"Lee YC, Milne R, Simth C et al (2016) Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 34 (suppl: abstr 1529)","DOI":"10.1200\/JCO.2016.34.15_suppl.1529"},{"issue":"3","key":"9977_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00404-010-1476-3","volume":"283","author":"K Rhiem","year":"2011","unstructured":"Rhiem K, Foth D, Wappenschmidt B et al (2011) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers. Arch Gynecol Obstet 283(3):623\u2013627. doi: 10.1007\/s00404-010-1476-3","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"9977_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ygyno.2012.08.023","volume":"127","author":"ME Sherman","year":"2012","unstructured":"Sherman ME, Guido R, Wentzensen N, Yang HP, Mai PL, Greene MH (2012) New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research. Gynecol Oncol 127(3):645\u2013650. doi: 10.1016\/j.ygyno.2012.08.023","journal-title":"Gynecol Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-017-9977-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-9977-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-9977-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:39:25Z","timestamp":1568911165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-017-9977-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["9977"],"URL":"https:\/\/doi.org\/10.1007\/s10689-017-9977-x","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2017,3,11]]}}}